1. Lin, Mei-Si, Zhong, Hui-Yun, Yim, Rita Lok-Hay, Gao, Fei, Zhang, Min-Yue. 2022. Pan-cancer analysis of oncogenic TNFAIP2 identifying its prognostic value and immunological function in acute myeloid leukemia. In BMC cancer, 22, 1068. doi:10.1186/s12885-022-10155-9. https://pubmed.ncbi.nlm.nih.gov/36243694/
2. Jia, Lin, Shi, Yundong, Wen, Yi, Feng, Jing, Chen, Ceshi. 2018. The roles of TNFAIP2 in cancers and infectious diseases. In Journal of cellular and molecular medicine, 22, 5188-5195. doi:10.1111/jcmm.13822. https://pubmed.ncbi.nlm.nih.gov/30145807/
3. Guo, Fang, Xu, Qian, Lv, Zhi, Zheng, Zhen-Dong, Yuan, Yuan. 2020. Correlation Between TNFAIP2 Gene Polymorphism and Prediction/Prognosis for Gastric Cancer and Its Effect on TNFAIP2 Protein Expression. In Frontiers in oncology, 10, 1127. doi:10.3389/fonc.2020.01127. https://pubmed.ncbi.nlm.nih.gov/32793480/
4. Ren, Wenlong, Liang, Huichun, Sun, Jian, Zhou, Zhongmei, Chen, Ceshi. 2024. TNFAIP2 promotes HIF1α transcription and breast cancer angiogenesis by activating the Rac1-ERK-AP1 signaling axis. In Cell death & disease, 15, 821. doi:10.1038/s41419-024-07223-2. https://pubmed.ncbi.nlm.nih.gov/39532855/
5. Thair, Simone A, Topchiy, Elena, Boyd, John H, Russell, James A, Walley, Keith R. 2015. TNFAIP2 Inhibits Early TNFα-Induced NF-x03BA;B Signaling and Decreases Survival in Septic Shock Patients. In Journal of innate immunity, 8, 57-66. doi:10.1159/000437330. https://pubmed.ncbi.nlm.nih.gov/26347487/
智鼠故事 
